Examples: Prince; Princeton University; Ken Follett; Follett,Ken
1shortlisttitle datasearch history  
results search [or] (ISNI Number (ISN:)) 0000000121374333 | 1 hits
Person
ISNI: 
0000 0001 2137 4333
Name: 
Riederer, P.
Riederer, Peter
Riederer, Peter F.
Riederer, Peter Franz
Riederer, Peter Franz (Vollstaendiger Name)
Dates: 
1942-
Creation class: 
cre
Language material
Text
Creation role: 
author
contributor
creator
editor
redactor
Related names: 
Beckmann, Helmut (1940-)
Birkmayer, W. (1910-1996)
Birkmayer, Walther
Birkmayer, Walther (1910-1996)
Gerlach, Manfred (1954-)
Jellinger, K. (1931-)
Jellinger, Kurt (1931-)
Ludwig Boltzmann-Institut für Klinische Neurobiologie
Pöldinger, Walter
Przuntek, Horst (1938-)
Reichmann, Heinz (1931-)
Youdim, Moussa B. H.
Titles: 
4. Drei-Länder-Symposium für Biologische Psychiatrie Würzburg, 10. - 12. Oktober 1996
Alzheimer's disease : epidemiology, neuropathology, neurochemistry, and clinics
Amine oxidases and their impact on neurobiology : proceedings of the 4th International amine oxidases workshop, Würzburg, Federal Republic of Germany, July 7-10, 1990
Basic aspects of receptor biochemistry : proceedings of the international symposium, Vienna, September 10-12, 1982
Biogene Transmitter und Akupunktur
Current topics in extrapyramidal disorders, 1980 (a.e.)
Depression Biochemie, Klinik, Therapie
Early diagnosis and preventive therapy in Parkinson's disease
Elektrizitätsversorgung der Stadt St. Gallen, Die
Focus on extrapyramidal dysfunction
Grundlagen der Neuro-Psychopharmakologie ein Therapiehandbuch
Introduction to neurotransmission in health and disease, An
Iron in central nervous system disorders
L-Dopa-Substitution der Parkinson-Krankheit Geschichte - Gegenwart - Zukunft
MAO-B-inhibitor selegiline (R-(-)-Deprenyl) a new therapeut. concept in the treatment of Parkinson's disease ; proceedings of the internat. symposium in Berlin, January 23 - 25, 1987
MAO-B-Inhibitor Selegiline (R-( - )-Deprenyl) : a new therapeutic concept in the treatment of Parkinson's disease : proceedings of the international symposium in Berlin, Jan. 23-25, 1987
MAO-B-inhibitor selegiline (R-(-)-deprenyl) : a new therapeutic concept in the treatment of Parkinson's disease : proceedings of the international symposium in Berlin, January 23-25, 1987
Monoamine oxidase and its selective inhibitors
Morbus Parkinson Selegilin (R-(-)-Deprenyl) ; Movergan ; e. neues Therapiekonzept
Neuro-Psychopharmaka ein Therapie-Handbuch
Neuroprotection in neurodegeneration. -
Neurotransmitter und menschliches Verhalten.
Neurotransmitters in cerebral coma and stroke : proceedings of the workshop, Vienna, July 11, 1978
Oxidative stress and neuroprotection
Parkinson-Krankheit Biochemie, Klinik, Therapie, Die
Parkinson-Krankheit Grundlagen, Klinik, Therapie, Die
Parkinson's disease and related disorders
Parkinson's disease : biochemistry, clinical pathology, and treatment
Pathobiology and clinics of basal ganglia disorders
Pathochemical markers in major ... 1984:
Pathochemical markers in major psychoses
Role of brain dopamine, The
Selegiline and neuroprotection in Parkinson's disease
Thermal room modelling adapted to the test of HVAC control systems
Understanding the neurotransmitters : key to the workings of the brain
Viertes Drei-Länder-Symposium für Biologische Psychiatrie
Notes: 
Sources: 
VIAF BNF DNB LC LNB NTA NUKAT SUDOC WKP
TEL